Syndax Pharmaceuticals (SNDX) Stock: Buy, Sell, or Hold?
$9.49
-0.06 (-0.63%)
▼
5d:
-33.59%
30d:
-42.66%
90d:
-52.07%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (84%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$11.30 – $16.24
Position: OVERSOLD
Forward P/E & Valuation
-12.1x
CHEAP
vs 126.3x historical avg
Wall Street Target
$35.45
+273.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.15 / $14.69
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: SNDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When SNDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SNDX is currently trading at $9.49, which is considered oversold relative to its 30-day fair value range of $11.30 to $16.24. From a valuation perspective, the stock is trading at a discount (Forward PE: -12.1) compared to its historical average (126.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SNDX is in a strong downtrend. Immediate support is located at $9.14, while resistance sits at $14.69.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.45 (+273.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNDX is in a strong downtrend. Immediate support is located at $9.14, while resistance sits at $14.69.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $35.45 (+273.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.30 -
$16.24
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
Trading Range & Key Levels
30-Day Trading Range
$11.30 -
$16.24
Current vs Trading Range
OVERSOLD
Support Level
$9.15
Resistance Level
$14.69
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding SNDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 273.6% below Wall St target ($35.45)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
- CAUTION: 5-day price weakness (-33.6%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-12.12
Wall Street Target
$35.45
(+273.6%)
Revenue Growth (YoY)
81.6%
Profit Margin
-72.3%
PE vs Historical
-12.1 vs 126.3
CHEAP
Share SNDX Analysis
Share this live SNDX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SNDX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Syndax Pharmaceuticals announced the hiring of a new CFO and the inducement grant given to him in connection to his employment, with shares vesting over a four-year period.
Key Retail Themes:
New CFO hire
Inducement grant
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 10:14 PM ET
Data refreshes hourly during market hours. Next update: 11:14 PM
Data refreshes hourly during market hours. Next update: 11:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 60 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 53 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 41 HOLD |
Advanced SNDX Option Strategies
Professional options setups generated by AI based on today's SNDX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SNDX Research Pages
